✦ LIBER ✦

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma

✍ Scribed by Litzow, M R; Peethambaram, P P; Safgren, S L; Keeney, G L; Ansell, S M; Dispenzieri, A; Elliott, M A; Gastineau, D A; Gertz, M A; Inwards, D J

Book ID: 109840768
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 189 KB
Volume: 45
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2009.181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of single agent cetuximab

Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

✍ Russell J. Schilder; Harsh B. Pathak; Anna E. Lokshin; Robert W. Holloway; Ronal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 425 KB

A phase II trial of pemetrexed in combin

A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer

✍ Jalid Sehouli; Ana Maria Alvarez; Shokoufeh Manouchehrpour; Prafull Ghatage; Cez 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 184 KB

A phase I study of intraperitoneal carbo

A phase I study of intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in patients with previously untreated epithelial ovarian carcinoma or primary peritoneal carcinoma

✍ O’Malley, D.; Eisenhauer, E.; McCann, G.; Salani, R.; Backes, F.; Copeland, L.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Phase I trial and pharmacokinetics of es

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma

✍ Philip C. Amrein; John R. Clark; Jeffrey G. Supko; Richard L. Fabian; Chiu C. Wa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND Amifostine was developed to protect normal tissues from radiation exposure. The current study was undertaken to determine whether amifostine would allow the delivery of greater numbers of weekly paclitaxel treatments with concomitant, hyperfractionated radiotherapy in pat